Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis

BACKGROUND: Musculoskeletal ultrasound (MSUS) and the multi-biomarker disease activity (MBDA) score are outcome measures that may aid in the management of rheumatoid arthritis (RA) patients. This study evaluated tofacitinib response by MSUS/MBDA scores and assessed whether baseline MSUS/MBDA scores...

Descripción completa

Detalles Bibliográficos
Autores principales: Razmjou, Amir A., Brook, Jenny, Elashoff, David, Kaeley, Gurjit, Choi, Soo, Kermani, Tanaz, Ranganath, Veena K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569763/
https://www.ncbi.nlm.nih.gov/pubmed/33089069
http://dx.doi.org/10.1186/s41927-020-00153-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569763/
https://www.ncbi.nlm.nih.gov/pubmed/33089069
http://dx.doi.org/10.1186/s41927-020-00153-4

Ejemplares similares